Structural basis of SARS-CoV-2 main protease inhibition by a broad-spectrum anti-coronaviral drug.

Yuchuan Wang, Wenhao Yang, Chia‐Shin Yang, Mei‐Hui Hou, Chia-Ling Tsai, Yi-Zhen Chou, Mien‐Chie Hung, Yeh Chen

PubMed · 2020 · 71 citations · 24 references

Full text

Open access

Concepts

Abstract

covalently linked through forming a hemithioacetal group and releasing a sulfonic acid group. Because GC376 is already known as a broad-spectrum antiviral medication and successfully used in animal, it will be a suitable candidate for anti-COVID-19 treatment.

References

24